Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation

Cancer

Volumn 97, Issue 5, 2003, Pages 1253-1262

  Komorizono, Yasuji ^a   Oketani, Makoto ^a   Sako, Katsumi ^b   Yamasaki, Naruhiro ^a   Shibatou, Toshihiko ^a   Maeda, Masahiko ^a   Kohara, Kazunori ^a   Shigenobu, Shuhou ^a   Ishibashi, Kazuaki ^a   Arima, Terukatsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Nanpuh Hospital   (Japan)

Author keywords

Hepatocellular carcinoma; Local recurrence; Percutaneous; Risk factors; Single radiofrequency ablation

Indexed keywords

ATARAX P; ATROPINE; DIAZEPAM; EPIRUBICIN; HYDROXYZINE; IODINATED POPPYSEED OIL; MITOMYCIN C; PENTAZOCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ARTICLE; BRADYCARDIA; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRODE; FEMALE; FOLLOW UP; HEMOPERITONEUM; HORIZON; HUMAN; HYPOTENSION; IMAGE ANALYSIS; IMPEDANCE; KAPLAN MEIER METHOD; LIVER BLOOD VESSEL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PAIN; PERCUTANEOUS RADIOFREQUENCY ABLATION; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; RANK SUM TEST; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RISK FACTORS;

EID: 0037372221     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11168     Document Type: Article

References (41)

1. Okuda K. Hepatocellular carcinoma. J Hepatol. 2000;32:225-237.
2. Bruix J. Treatment of hepatocellular carcinoma. Hepatology. 1997;25:259-262.
3. Johnson P, Bruix J. Hepatocellular carcinoma and the art of prognostication. J Hepatol. 2000;33:1006-1008.
4. Okuda K. Hepatocellular carcinoma: recent progression. Hepatology. 1993;15:948-963.
5. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med. 1993;328:1797-1801.
6. Sugiura N, Takara K, Teratani T, et al. Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real-time ultrasound monitoring. Acuta Hepatol Jpn. 1983;24:920.
7. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol. 1993;160:1023-1028.
8. Castells A, Bruix J, Bru C, et al. Treatment of small hepato-cellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 1993;18:1121-1126.
9. Livraghi T, Bolondi L, Buscarini L, et al. No treatment, resection and ethanol injection in hepatocellular carcinoma. A retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol. 1995;22:522-526.
10. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990;25:267-270.
11. Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori. 1990;76:54-57.
12. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol. 1998;170:1015-1022.
13. Goldberg SN, Gazelle GS, Solbiati L, Rittman WJ, Mueller PR. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol. 1996;3:636-644.
14. Barnett CC Jr., Curley SA. Ablative techniques for hepato-cellular carcinoma. Semin Oncol. 2001;28:487-496.
15. Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-391.
16. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655-661.
17. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000;214:761-768.
18. Lafortune M, Madore F, Patriquin H, Breton G. Segmental anatomy of the liver: a sonographic approach to the Couinaud nomenclature. Radiology. 1991;181:443-448.
19. Pugh RNH, Murray-Lyon IM, Dawson JL, Pierroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
20. McGahan JP, Dodd GD III. Radiofrequency ablation of the liver: current status [review]. Am J Roentgenol. 2001;176:3-16.
21. de Baere T, Denys A, Johns Wood B, et al. Radiofrequency liver ablation: experimental comparative study of water-cooled versus expandable systems. AJR Am J Roentgenol. 2001;176:187-192.
22. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124-1129.
23. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000:217:119-126.
24. Cady B, Jenkins RL, Steele GD Jr., et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566-571.
25. Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381-388.
26. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery. 2002;131:311-317.
27. Poon RT, Fan ST, Ng IO, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg. 2000;231:544-551.
28. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500-517.
29. Nagasue N, Ono T, Yamanoi A, et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg. 2001;88:515-522.
30. Bolondi L, Gaiani S, Celli N, Piscaglia F. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology. 2001;34:608;discussion, 610-611.
31. Livraghi T. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology. 2001;34:608-609; discussion, 610-611.
32. Goldberg SN, Solbiati L. Tumor dissemination after radio-frequency ablation of hepatocellular carcinoma. Hepatology. 2001;34:609; discussion, 610-611.
33. de Sio I, Castellano L, De Girolamo V, et al. Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology. 2001;34;609-610; discussion, 610-611.
34. Patterson EJ, Scudamore CH, Owen DA, Nagy AG, Buczkowski AK. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg. 1998;227:559-565.
35. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol. 1998;9:101-111.
36. Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E. Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver. 1999;19:12-18.
37. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000;33:282-289.
38. Buscarini L, Buscarini E, Di Stasi M, Quaretti P, Zangrandi A. Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med. 1999;20:47-53.
39. Arata MA, Nisenbaum HL, Clark TW, Soulen MC. Percutaneous radiofrequency ablation of liver tumors with the LeVeen probe: is roll-off predictive of response? J Vasc Interv Radiol. 2001;12:455-458.
40. Seki T, Tamai T, Ikeda K, et al. Rapid progression of hepatocellular carcinoma after transcatheter arterial chemoembolization and percutaneous radiofrequency ablation in the primary tumour region. Eur J Gastroenterol Hepatol. 2001;13:291-294.
41. Hasegawa S, Yamasaki N, Hiwaki T, et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer. 1999;86:1682-1690.